Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Jul;40 Suppl 1(Suppl 1):i16-20.
doi: 10.1136/bjsm.2006.027557.

Central nervous system stimulants and sport practice

Affiliations
Review

Central nervous system stimulants and sport practice

L Avois et al. Br J Sports Med. 2006 Jul.

Abstract

Background and objectives: Central nervous system (CNS) stimulants may be used to reduce tiredness and increase alertness, competitiveness, and aggression. They are more likely to be used in competition but may be used during training to increase the intensity of the training session. There are several potential dangers involving their misuse in contact sports. This paper reviews the three main CNS stimulants, ephedrine, amfetamine, and cocaine, in relation to misuse in sport.

Methods: Description of the pharmacology, actions, and side effects of amfetamine, cocaine, and ephedrine.

Results: CNS stimulants have psychotropic effects that may be perceived to be ergogenic. Some are prescription drugs, such as Ephedra alkaloids, and there are issues regarding their appropriate therapeutic use. Recently attention has been given to their widespread use by athletes, despite the lack of evidence regarding any ergogenic or real performance benefit, and their potentially serious side effects. Recreational drugs, some of which are illegal (cocaine, amfetamines), are commonly used by athletes and cause potential ergolytic effects. Overall, these drugs are important for their frequent use and mention in anti-doping laboratories statistics and the media, and their potentially serious adverse effects.

Conclusions: Doping with CNS stimulants is a real public health problem and all sports authorities should participate in its prevention. Dissemination of information is essential to prevent doping in sport and to provide alternatives. Adequate training and education in this domain should be introduced.

PubMed Disclaimer

Conflict of interest statement

Competing interests: none declared

References

    1. World Anti‐Doping Agency website: www.wada‐ama.org
    1. George A J. CNS stimulants. In: Mottram DR, ed. Drugs in Sports, 2nd edn. London: E and F Spon, 1996
    1. Schwenk T L. Psychoactive drugs and athletic performance. Phys Sportsmed 19972532–46. - PubMed
    1. Smith D A, Perry P J. Part II, other performance‐enhancing agents. The efficacy of ergogenic agents in athletic competition. Ann Pharmacother 199226653–659. - PubMed
    1. Eichner E R. Ergolytic drugs in medicine and sports. Am J Med 199394205–211. - PubMed

MeSH terms